Federal officials to deliver briefing on COVID-19 as case counts increase
OTTAWA — Health Canada says it needs more information before it can make a decision on a COVID-19 vaccine manufactured by AstraZeneca.
The agency says in a statement this morning it is working with international counterparts like those in the U.K. to share information on vaccines under review.
Earlier today, the U.K. became the first country to authorize use of the vaccine created by AstraZeneca and Oxford University.
Despite that, Health Canada says it cannot provide a definite timeline for completion of its review of the vaccine.